JP2024512874A5 - - Google Patents
Info
- Publication number
- JP2024512874A5 JP2024512874A5 JP2023547499A JP2023547499A JP2024512874A5 JP 2024512874 A5 JP2024512874 A5 JP 2024512874A5 JP 2023547499 A JP2023547499 A JP 2023547499A JP 2023547499 A JP2023547499 A JP 2023547499A JP 2024512874 A5 JP2024512874 A5 JP 2024512874A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- c6alkyl
- halogen
- cyano
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163146312P | 2021-02-05 | 2021-02-05 | |
| US63/146,312 | 2021-02-05 | ||
| US202163223255P | 2021-07-19 | 2021-07-19 | |
| US63/223,255 | 2021-07-19 | ||
| US202163242260P | 2021-09-09 | 2021-09-09 | |
| US63/242,260 | 2021-09-09 | ||
| PCT/US2022/015353 WO2022170122A1 (en) | 2021-02-05 | 2022-02-04 | Quinoxaline derivatives and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512874A JP2024512874A (ja) | 2024-03-21 |
| JP2024512874A5 true JP2024512874A5 (https=) | 2025-02-13 |
Family
ID=80446119
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023547499A Pending JP2024512874A (ja) | 2021-02-05 | 2022-02-04 | キノキサリン誘導体及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240368181A1 (https=) |
| EP (1) | EP4288426B8 (https=) |
| JP (1) | JP2024512874A (https=) |
| KR (1) | KR20240006494A (https=) |
| AU (1) | AU2022215616A1 (https=) |
| CA (1) | CA3207475A1 (https=) |
| DK (1) | DK4288426T3 (https=) |
| FI (1) | FI4288426T3 (https=) |
| MX (1) | MX2023009166A (https=) |
| WO (1) | WO2022170122A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4543870A1 (en) * | 2022-06-24 | 2025-04-30 | F. Hoffmann-La Roche AG | New heterocyclic-carbonyl-cyclic compounds as magl inhibitors |
| AU2023338193A1 (en) * | 2022-09-07 | 2025-03-20 | Eli Lilly And Company | Pyrazolo[1,5-a]pyridine and imidazo[1,2-a]pyridine derivatives as fgfr3 inhibitors for the treatment of cancer |
| WO2025117550A1 (en) * | 2023-12-01 | 2025-06-05 | Black Diamond Therapeutics, Inc. | Solid state forms of a quinoxaline derivative useful in the treatment of cancer |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US5763263A (en) | 1995-11-27 | 1998-06-09 | Dehlinger; Peter J. | Method and apparatus for producing position addressable combinatorial libraries |
| WO2005007099A2 (en) * | 2003-07-10 | 2005-01-27 | Imclone Systems Incorporated | Pkb inhibitors as anti-tumor agents |
| EP2806874B1 (en) * | 2012-01-25 | 2017-11-15 | Neupharma, Inc. | Quinoxaline-oxy-phenyl derivatives as kinase inhibitors |
| JO3512B1 (ar) * | 2014-03-26 | 2020-07-05 | Astex Therapeutics Ltd | مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز |
-
2022
- 2022-02-04 KR KR1020237029950A patent/KR20240006494A/ko active Pending
- 2022-02-04 FI FIEP22705676.9T patent/FI4288426T3/fi active
- 2022-02-04 WO PCT/US2022/015353 patent/WO2022170122A1/en not_active Ceased
- 2022-02-04 JP JP2023547499A patent/JP2024512874A/ja active Pending
- 2022-02-04 US US18/275,232 patent/US20240368181A1/en active Pending
- 2022-02-04 MX MX2023009166A patent/MX2023009166A/es unknown
- 2022-02-04 AU AU2022215616A patent/AU2022215616A1/en active Pending
- 2022-02-04 EP EP22705676.9A patent/EP4288426B8/en active Active
- 2022-02-04 DK DK22705676.9T patent/DK4288426T3/da active
- 2022-02-04 CA CA3207475A patent/CA3207475A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024512874A5 (https=) | ||
| RU2014115847A (ru) | Пирролопиримидиновые соединения для лечения злокачественной опухоли | |
| JP2013510860A5 (https=) | ||
| JP2019512478A5 (https=) | ||
| JP2008528671A5 (https=) | ||
| JP2020517616A5 (https=) | ||
| JP2012505235A5 (https=) | ||
| JP2019535746A5 (https=) | ||
| JP2002525284A5 (https=) | ||
| JP2014528466A5 (https=) | ||
| RU2006122853A (ru) | Производные диарилмочевины для лечения заболеваний, зависимых от протеинкиназы | |
| JP2006528162A (ja) | 化合物 | |
| JP2005524631A5 (https=) | ||
| JP2008533191A5 (https=) | ||
| JP2013538213A5 (https=) | ||
| RU99128053A (ru) | Новые циклические соединения диамина и содержащие их лекарственные средства | |
| EP3411121B1 (en) | Glucose conjugates of triptolide, analogs and uses thereof | |
| CA2550350A1 (en) | 2-(hetero)aryl-substituted tetrahydroquinoline derivatives | |
| RU2018134336A (ru) | Комбинированная терапия сорафенибом или регорафенибом и фосфорамидатным пролекарством троксацитабина | |
| JP2008508287A5 (https=) | ||
| JP2008506710A5 (https=) | ||
| JP2017534657A (ja) | 新型シチジン誘導体およびその適用 | |
| JP2014533727A5 (https=) | ||
| RU2007116987A (ru) | Новые соединения | |
| RU2005106863A (ru) | Противоопухолевые аналоги ламелларина |